Abstract:PURPOSE: The objective of this study was to investigate the independent risk factors and associated predictive values of contrast-enhanced ultrasound (CEUS), shear wave elastography (SWE), and strain elastography (SE) for high-risk lesions (HRL) and malignant tumors (MT) among nonpalpable breast masses classified as BI-RADS category 4 on conventional ultrasound.METHODS: This prospective study involved consecutively admitted patients with breast tumors from January 2018, aiming to explore the management of BI-RADS category 4 breast tumors using CEUS and elastography. We conducted a retrospective review of patient data, focusing on those with a history of a nonpalpable mass as the primary complaint. Pathologic findings after surgical resection served as the gold standard. The CEUS arterial-phase indices were analyzed using contrast agent arrival-time parametric imaging processing mode, while quantitative and qualitative indices were examined on ES images. Independent risk factors were identified through binary logistic regression multifactorial analysis. The predictive efficacy of different modalities was compared using a receiver operating characteristics curve. Subsequently, a nomogram for predicting the risk of HRL/MT was established based on a multifactorial logistic regression model.RESULTS: A total of 146 breast masses from 146 patients were included, comprising 80 benign tumors, 12 HRLs, and 54 MTs based on the final pathology. There was no significant difference in pathologic size between the benign and HRL/MT groups [8.00(6.25,10.00) vs. 9.00(6.00,10.00), P = 0.506]. The diagnostic efficacy of US plus CEUS exceeded that of US plus SWE/SE for BI-RADS 4 nonpalpable masses, with an AUC of 0.954 compared to 0.798/0.741 (P < 0.001). Further stratified analysis revealed a more pronounced improvement for reclassification of BI-RADS 4a masses (AUC: 0.943 vs. 0.762/0.675, P < 0.001) than BI-RADS 4b (AUC:0.950 vs. 0.885/0.796, P>0.05) with the assistance of CEUS than SWE/SE. Employing downgrade CEUS strategies resulted in negative predictive values ranging from 95.2 % to 100.0 % for BI-RADS 4a and 4b masses. Conversely, using upgrade nomogram strategies, which included the independent predictive risk factors of irregular enhanced shape, poor defined enhanced margin, earlier enhanced time, increased surrounding vessels, and presence of contrast agent retention, the diagnostic performance achieved an AUC of 0.947 with good calibration.CONCLUSION: After investigating the potential of CEUS and ES in improving risk assessment and diagnostic accuracy for nonpalpable BI-RADS category 4 breast masses, it is evident that CEUS has a more significant impact on enhancing classification compared to ES, particularly for BI-RADS 4a subgroup masses. This finding suggests that CEUS may offer greater benefits in improving risk assessment and diagnostic accuracy for this specific subgroup of breast masses.

The Application Value of Using Semiquantitative and Quantitative Parameters in Multimodal Ultrasound to Distinguish Between Benign and Malignant BI-RADS 4 Lesions

Value of Scoring by Contrast-Enhanced Ultrasound Combined with Ultrasonic Elastography in Differential Diagnosis of BI-RADS 4 Lesions

The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RA DS 4 lesions detected by magnetic resonance imaging

The value of three-dimensional ultrasonography and mammography in the diagnosis of breast lesions

The Differential Diagnostic Value of Contrast-enhanced Ultrasonography in BI-RADSUS 4B Breast Lesions

Significance and Feasibility of the Application of Contrast-Enhanced Ultrasound in Breast Imaging Reporting and Data System

Application of Contrast-Enhanced Ultrasound in the Diagnosis of Small Breast Lesions

The Value of Conventional Ultrasound Combined with Virtual Touch Tissue Imaging in Differentiating Benign and Malignant Breast Lesions

Diagnosis of Benign and Malignant BI-RADS 4 Breast Masses by Contrastenhanced Ultrasound Combined with Shear Wave Elastography

Value of Ultrasound Elastography Combined with Contrast-Enhanced Ultrasound and Micro-Flow Imaging in Differential Diagnosis of Benign and Malignant Breast Lesions.

The value of ultrasound elastography combined with multi-parameters in the diagnosis of BI-RADS 4 breast lesions

Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses

Combined Use of the Ultrasound Elastography and the Automated Breast Volume Scanner in Differentiation of Benign and Malignant Breast Imaging Reporting and Data System 4 Breast Lesions

Evaluating diagnostic significance: The utilization of elastography and contrast-enhanced ultrasound for differential diagnosis in breast lesions

Differentiating Benign from Malignant Solid Breast Lesions: Combined Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Comparison with Magnetic Resonance Imaging.

Evaluation of Breast Lesions by Contrast Enhanced Ultrasound: Qualitative and Quantitative Analysis.

Application Value of Conventional Ultrasound Classification and Contrast-Enhanced Ultrasound in Non-Mass Breast-Like Lesions

Conventional ultrasound combined with contrast-enhanced ultrasound in diagnosis of benign and malignant breast tumors

Virtual Touch Tissue Imaging and Quantification: Value in Malignancy Prediction for Complex Cystic and Solid Breast Lesions

Adjunctive Targeted Contrast-Enhanced Ultrasonography for the Work-Up of Breast Imaging Reporting and Data System Category 3 and 4 Lesions.

Contrast-enhanced ultrasound diagnosis of BI-RADS 4 breast lesions -- a comparative study with dynamic contrast-enhanced magnetic resonance imaging